1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma

Technology appraisal guidance [TA137] Published: 27 February 2008

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Information for the public


  • Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma PDF 145 KB 27 February 2008  
  • Gwybodaeth i'r cyhoedd Word 238 KB 15 September 2008